BIONET Therapeutics Corp. (TPEX:7808)
Taiwan · Delayed Price · Currency is TWD 55.20
-0.30 (-0.54%)
At close: Jan 20, 2026
BIONET Therapeutics Market Cap
BIONET Therapeutics has a market cap or net worth of 3.81 billion as of January 21, 2026. Its market cap has increased by 13.33% in one year.
Market Cap
3.81B
Enterprise Value
2.68B
Revenue
105.67M
Ranking
n/a
PE Ratio
n/a
Stock Price
55.20
Market Cap Chart
Since December 12, 2024, BIONET Therapeutics's market cap has decreased from 3.82B to 3.81B, a decrease of -0.18%. That is a compound annual growth rate of -0.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 21, 2026 | 3.81B | -3.20% |
| Dec 31, 2025 | 3.93B | 20.99% |
| Dec 31, 2024 | 3.25B | -14.77% |
| Dec 12, 2024 | 3.82B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tait Marketing & Distribution | 3.90B |
| EASYCARD | 3.89B |
| Orient EuroPharma | 3.87B |
| Minson Integration | 3.87B |
| Major-Power Technology | 3.84B |
| Celxpert Energy | 3.84B |
| YFC-Boneagle Electric | 3.83B |
| Value Valves | 3.83B |